LONG ISLAND, NY (MARKET WIRE) SciMeDent Health, Corp. f/k/a Trend Exploration, Inc. ("TRDX" or the "Company") (PINKSHEETS: TRDX) recently executed a Letter of Intent with Genesis Biopharma, Inc. ("Genesis") to advance development of a cure to one of the major problems facing people suffering from diabetes -- NEUROPATHY.